Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1916-0216
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prospective pilot study of Floseal® for the treatment of anterior epistaxis in patients with hereditary hemorrhagic telangiectasia (HHT) ; volume:48 ; number:1 ; day:15 ; month:10 ; year:2019 ; pages:1-5 ; date:12.2019
Journal of otolaryngology, head & neck surgery ; 48, Heft 1 (15.10.2019), 1-5, 12.2019
- Creator
-
Lee, John M.
Wu, Vincent
Faughnan, Marie E.
Lasso, Andrea
Figol, Andrea
Kilty, Shaun J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40463-019-0379-y
- URN
-
urn:nbn:de:101:1-2020021100501196959383
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, John M.
- Wu, Vincent
- Faughnan, Marie E.
- Lasso, Andrea
- Figol, Andrea
- Kilty, Shaun J.
- SpringerLink (Online service)
Other Objects (12)
Imaging of Hereditary Hemorrhagic Telangiectasia
Future treatments for hereditary hemorrhagic telangiectasia
Severity score for hereditary hemorrhagic telangiectasia
Brain abscess and hereditary hemorrhagic telangiectasia
Employment of diverse in vitro systems for analyzing multiple aspects of disease, hereditary hemorrhagic telangiectasia (HHT)
Gender differences in hereditary hemorrhagic telangiectasia severity
Hypercoagulability in hereditary hemorrhagic telangiectasia with epilepsy
Angiogenesis, hereditary hemorrhagic telangiectasia and COVID-19
Hemorrhagic pericardial effusion resulting in constriction in hereditary hemorrhagic telangiectasia
Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)
Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers
Conservative management by embolization of a ruptured renal arterio-venous malformation (AVM) in Hereditary Hemorrhagic Telangiectasia (HHT)
Imaging of Hereditary Hemorrhagic Telangiectasia
Future treatments for hereditary hemorrhagic telangiectasia
Severity score for hereditary hemorrhagic telangiectasia
Brain abscess and hereditary hemorrhagic telangiectasia
Employment of diverse in vitro systems for analyzing multiple aspects of disease, hereditary hemorrhagic telangiectasia (HHT)
Gender differences in hereditary hemorrhagic telangiectasia severity
Hypercoagulability in hereditary hemorrhagic telangiectasia with epilepsy
Angiogenesis, hereditary hemorrhagic telangiectasia and COVID-19
Hemorrhagic pericardial effusion resulting in constriction in hereditary hemorrhagic telangiectasia
Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)
Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers
Conservative management by embolization of a ruptured renal arterio-venous malformation (AVM) in Hereditary Hemorrhagic Telangiectasia (HHT)
Imaging of Hereditary Hemorrhagic Telangiectasia
Future treatments for hereditary hemorrhagic telangiectasia
Severity score for hereditary hemorrhagic telangiectasia
Brain abscess and hereditary hemorrhagic telangiectasia
Employment of diverse in vitro systems for analyzing multiple aspects of disease, hereditary hemorrhagic telangiectasia (HHT)
Gender differences in hereditary hemorrhagic telangiectasia severity
Hypercoagulability in hereditary hemorrhagic telangiectasia with epilepsy
Angiogenesis, hereditary hemorrhagic telangiectasia and COVID-19
Hemorrhagic pericardial effusion resulting in constriction in hereditary hemorrhagic telangiectasia
Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)
Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers